Baird Operating Cycle from 2010 to 2026

BDMD Stock   2.36  0.53  28.96%   
Baird Medical's Operating Cycle is increasing over the years with slightly volatile fluctuation. Operating Cycle is expected to dwindle to 317.88. During the period from 2010 to 2026 Baird Medical Operating Cycle annual values regression line had geometric mean of  360.41 and mean square error of  4,529. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
510.3
Current Value
317.88
Quarterly Volatility
76.13116184
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Baird Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Baird Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Interest Expense of 696.4 K or Selling General Administrative of 5.7 M, as well as many indicators such as Price To Sales Ratio of 3.98, Dividend Yield of 0.0613 or PTB Ratio of 3.97. Baird financial statements analysis is a perfect complement when working with Baird Medical Valuation or Volatility modules.
  
Build AI portfolio with Baird Stock
Check out the analysis of Baird Medical Correlation against competitors.
Analyzing Baird Medical's Operating Cycle over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Cycle has evolved provides context for assessing Baird Medical's current valuation and future prospects.

Latest Baird Medical's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Baird Medical Investment over the last few years. It is Baird Medical's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Baird Medical's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Baird Operating Cycle Regression Statistics

Arithmetic Mean366.68
Geometric Mean360.41
Coefficient Of Variation20.76
Mean Deviation56.94
Median335.69
Standard Deviation76.13
Sample Variance5,796
Range283
R-Value0.52
Mean Square Error4,529
R-Squared0.27
Significance0.03
Slope7.80
Total Sum of Squares92,735

Baird Operating Cycle History

2026 317.88
2025 510.3
2024 567.0
2023 464.08
2022 324.49
2021 409.33
2020 283.53

About Baird Medical Financial Statements

Baird Medical stakeholders use historical fundamental indicators, such as Baird Medical's Operating Cycle, to determine how well the company is positioned to perform in the future. Although Baird Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Baird Medical's assets and liabilities are reflected in the revenues and expenses on Baird Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Baird Medical Investment. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Cycle 510.30  317.88 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Baird Medical Investment is a strong investment it is important to analyze Baird Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Baird Medical's future performance. For an informed investment choice regarding Baird Stock, refer to the following important reports:
Check out the analysis of Baird Medical Correlation against competitors.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Will Health Care Equipment & Supplies sector continue expanding? Could Baird diversify its offerings? Factors like these will boost the valuation of Baird Medical. Projected growth potential of Baird fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Baird Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0)
Earnings Share
(0.11)
Revenue Per Share
1.226
Quarterly Revenue Growth
(0.39)
Return On Assets
(0)
Baird Medical Investment's market price often diverges from its book value, the accounting figure shown on Baird's balance sheet. Smart investors calculate Baird Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Baird Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Baird Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Baird Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Baird Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.